Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings

Author:

Luetkemeyer Anne F.,Firnhaber Cynthia,Kendall Michelle A.,Wu Xingye,Mazurek Gerald H.,Benator Debra A.,Arduino Roberto,Fernandez Michel,Guy Elizabeth,Johnson Pamela,Metchock Beverly,Sattler Fred,Telzak Edward,Wang Yun F.,Weiner Marc,Swindells Susan,Sanne Ian M.,Havlir Diane V.,Grinsztejn Beatriz,Alland David

Funder

National Institute of Allergy and Infectious Diseases

ACTG

the CDC

the TBTC and the Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention

National Institute of Mental Health

National Institute of Dental and Craniofacial Research

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference18 articles.

1. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults

2. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Policy statement. Geneva, Switzerland: WHO, 2011.

3. US Food and Drug Administration. FDA permits marketing of first U.S. test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm362602.htm . Accessed 1 December 2015.

4. US Food and Drug Administration. New data shows test can help physicians remove patients with suspected TB from isolation earlier. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm434226.htm . Accessed 12 February 2015.

5. Bevilaqua AA . Boletim tuberculose 2014 [in Portugese]. Available at: http://www.riocomsaude.rj.gov.br/Publico/MostrarArquivo.aspx?C=wXJ%2BKouHyII%3D . Accessed 28 August 2015.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3